4.9349
0.51%
0.0149
Schlusskurs vom Vortag:
$4.92
Offen:
$4.94
24-Stunden-Volumen:
493.82K
Relative Volume:
0.13
Marktkapitalisierung:
$1.17B
Einnahmen:
$251.85M
Nettoeinkommen (Verlust:
$-72.58M
KGV:
-41.12
EPS:
-0.12
Netto-Cashflow:
$-63.80M
1W Leistung:
+4.99%
1M Leistung:
-15.90%
6M Leistung:
-35.95%
1J Leistung:
+14.47%
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Vergleichen Sie ARDX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
ARDX | 4.945 | 1.17B | 251.85M | -72.58M | -63.80M | -0.12 |
VRTX | 447.62 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 742.10 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.10 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.88 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 103.40 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
2021-03-23 | Eingeleitet | Wedbush | Outperform |
2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-10-20 | Fortgesetzt | Citigroup | Buy |
2020-02-18 | Fortgesetzt | Jefferies | Buy |
2020-02-12 | Eingeleitet | Citigroup | Buy |
2020-02-10 | Eingeleitet | Cowen | Outperform |
2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
2018-08-24 | Eingeleitet | Jefferies | Buy |
2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
2017-11-29 | Bestätigt | Citigroup | Buy |
2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Ardelyx Executives to Present at Piper Sandler Healthcare Conference | ARDX Stock News - StockTitan
Jefferies optimistic on Ardelyx stock as management navigates reimbursement changes - Investing.com
US Penny Stocks To Monitor In November 2024 - Simply Wall St
Ardelyx, Inc. (NASDAQ:ARDX) Short Interest Up 5.1% in October - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Gap UpTime to Buy? - MarketBeat
Janus Henderson Group PLC's Strategic Reduction in Ardelyx Inc H - GuruFocus.com
Director David Mott Acquires 215,868 Shares of Ardelyx Inc (ARDX) - GuruFocus.com
Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability (NASDAQ:ARDX) - Seeking Alpha
HC Wainwright Has Bearish Forecast for Ardelyx Q1 Earnings - MarketBeat
Ardelyx (NASDAQ:ARDX) Rating Lowered to “Neutral” at HC Wainwright - Defense World
Ardelyx shares downgraded amid sales concerns for XPHOZAH By Investing.com - Investing.com Australia
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop - Seeking Alpha
Ardelyx (NASDAQ:ARDX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Ardelyx shares downgraded amid sales concerns for XPHOZAH - Investing.com India
Ardelyx (NASDAQ:ARDX) Lowered to Neutral Rating by HC Wainwright - MarketBeat
Ardelyx chief development officer sells shares worth $165,743 - Investing.com India
Ardelyx chief development officer sells shares worth $165,743 By Investing.com - Investing.com Australia
David P. Rosenbaum Sells 27,171 Shares of Ardelyx, Inc. (NASDAQ:ARDX) Stock - MarketBeat
Ardelyx Beats Q3 Sales Estimates, Shares Climb - MSN
Ardelyx Loses Bid to Block HHS Classification of Kidney Drug - Bloomberg Law
Ardelyx tumbles as lawsuit against CMS dismissed over Xphozah (update) - MSN
Ardelyx Responds to District Court Decision Granting Motion to Dismiss - The Manila Times
Ardelyx (NASDAQ:ARDX) Shares Gap DownTime to Sell? - MarketBeat
Ardelyx ‘disappointed’ by court decision granting motion to dismiss - TipRanks
Ardelyx Stock Alert: Court Dismisses CMS Lawsuit, XPHOZAH Access Concerns Mount | ARDX Stock News - StockTitan
Ardelyx falls after court dismisses lawsuit against CMS over company's kidney disease drug - XM
Ardelyx chief development officer sells $161,673 in stock - Investing.com
Ardelyx chief development officer sells $161,673 in stock By Investing.com - Investing.com Canada
(ARDX) Investment Analysis - Stock Traders Daily
Citigroup Lowers Ardelyx (NASDAQ:ARDX) Price Target to $10.00 - Defense World
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference - ForexTV.com
Ardelyx (ARDX) Leadership to Present at Jefferies London Healthcare Conference 2024 | ARDX Stock News - StockTitan
What is Wedbush’s Forecast for Ardelyx FY2026 Earnings? - Defense World
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Inve - GuruFocus.com
Ardelyx (NASDAQ:ARDX) Price Target Lowered to $10.00 at Citigroup - MarketBeat
Wedbush Has Negative Outlook for Ardelyx FY2026 Earnings - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Q3 2024 Earnings Call Transcript - MSN
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Simply Wall St
Ardelyx (NASDAQ:ARDX) Stock Price Up 7.3% – Here’s Why - Defense World
Allspring Global Investments Holdings LLC Sells 19,212 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seekin - GuruFocus.com
Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023) - Yahoo Finance
Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics - MSN
Ardelyx (NASDAQ:ARDX) Earns "Buy" Rating from HC Wainwright - MarketBeat
Earnings call: Ardelyx reports solid growth amid Medicare challenges - Investing.com
Earnings call: Ardelyx reports solid growth amid Medicare challenges By Investing.com - Investing.com Canada
Ardelyx (NASDAQ:ARDX) Shares Up 7.3%Should You Buy? - MarketBeat
Ardelyx Target of Unusually High Options Trading (NASDAQ:ARDX) - MarketBeat
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):